The continuing chalIenge of infectious diseases
No clinician working in the developing world can be unaware of the importance of infectious disease. The illnesses caused by virus, bacteria and protozoa make up a large part of the workload for all heaIthcare workers. But each country has its own pattern of disease, and in the local struggle it may be difficult to appreciate the larger battle.
Two important reports from the World Health Organization (WHO) give us a fascinating insight into the big picture. The 1999 report Removing Obstacles to Healthy Development' surveyed the extent of the problem, a follow-up report in 2000 Overcoming Antimicrobial Resistance' addressed in more detail one particularly worrying aspect of the fight against infectious diseases.
The science of ecology has taught us about the dynamic balance that exists between all living organisms. At a simplistic level microbes effect man, and man the microbe. Human interventions (be they economic, developmental, demographic, or even medical) shift the balance to favour one protagonist or the other. In some places there are important gains against infectious diseases, in others the microbe is in the ascendency. There is no clear global winner in sight.
The statistics of infectious diseases are truly alarming. These diseases account for more than 13 million deaths a year. Most of these deaths are in developing countries, where infections cause 45% of all deaths. Half of the victims are children aged under 5 years.
On a global level the statistics are dominated by six important illnesses: acute respiratory infections, HIV j AIDS, tuberculosis, diarrhoeal diseases, malaria and measles. These disease categories account for 90% of the deaths due to infectious disease as well as the majority of morbidity. For all of these illnesses simple and in many cases relatively cheap technologies already exist which have the potential to alter the balance of the battle in favour of humankind. WHO estimate that at least half of the deaths from infectious diseases could be prevented by the widespread application of vaccination, bed net and other antimalarial strategies, appropriate use of antibiotics [including the Directly Observed Therapy Shortcourse (DOTS) strategy for TB), integrated management of childhood illnesses (including the use of oral rehydration therapy), and HIV prevention work. As ever, the main barrier to the widespread application of these technologies is political and financial. In 1995 the world's nations spent $864 billion on fighting other humans, but only $15 billion on fighting HIV, Mycobacterium tuberculosis and plasmodia combined.
Examination of the situation at a district and country level reveals other issues of concern. The 1999 report details many examples of unexpected outbreaks, mostly of well-recognized diseases although in some cases of new ones. The past two decades has seen 30 emerging diseases identified in humans for the first time, including the appalling pandemic of AIDSjHIV. The same period has seen epidemics of many traditional diseases including Tropical Doctor October 2001,31 plague, cholera, typhoid, yellow fever, anthrax and meningitis. In many cases an outbreak or epidemic will be provoked or facilitated by an ecological change brought about by man. War, mass migration, impoverishment, deforestation, changing methods of agriculture, irrigation projects, dams and global warming are all cited. Of direct relevance to doctors is the largely iatrogenic and growing problem of antibiotic resistance; maybe we all bear some responsibility for the careless squandering of Fleming's legacy.
WHO has done the world a service in documenting the current situation; both the disappointments and the successes. In the future new drugs, vaccines and technologies may become available to help in the fight against the microbe. They will be welcome, but we would be naive to think that any scientific advance alone could tip the balance of this battle. That will require a profound, and global, change in our attitudes to the environment and to each other.
Polio: is the end in sight?
Poliomyelitis is certainly a word that has struck fear in the minds of countless generations over the years as millions of people throughout the world have been permanently lamed or worse still, asphyxiated by respiratory paralysis, as a result of this preventable disease.
The statistics in the past make sad reading and indicate what a heavy toll this infection has taken. Before the development of polio vaccines about 500000 people a year worldwide were paralysed or died after contracting the disease (see WHO, page 83)'; in 1988, when the World Health Organization (WHO) spearheaded the global eradication campaign, over 350000 cases were reported (see WHO, page 9W and in 1997 it was estimated that as many as 10-20 million people of all ages were living with paralysis caused by the poliovirus (see WHO, page I)'.
It is a disease that is no respecter of persons and among the victims were President Roosevelt of the USA and the Scottish novelist, Sir Walter Scott. As it was also an infection which sometimes singled out those who were especially keen on strenuous exercise which meant that the most vigorous members of society were at particular risk.
The development of an inactivated (killed) poliovaccine (lPV) by Dr Jonas Salk in 1955 and an attenuated, oral (live) poliovaccine (OPV) by Dr Albert Sabin in 1961 revolutionized the possibilities of protecting the population against polio. So successful have these vaccines been, that in recent years attention has been stimulated towards the possibility of global eradication.
The concept of eradication of a specific disease had already been shown to be possible with the campaign to eradicate smallpox from the world's population which came to a successful conclusion in October 1977 with the last endemic case occurring in Ethiopia (although two other cases were recorded less than a year later when they became infected with smallpox virus originating from a laboratory in Birmingham, England).
In partnership with Rotary International, UNICEF and the US Centers for Disease Control, the WHO acted on a resolution adopted at the World Health Assembly in 1988 calling for the global eradication of polio. This has produced a tremendous response. In 1996, 420 million children -almost two-thirds of the world's population were immunized during mass campaigns. In 1997, India succeeded in immunizing 127 million children in a single day -the largest health event ever organized by an individual country (see WHO, page 1)1.
As Maher and Aylward describe in their paper in this issue of Tropical Doctor (page 246) the diminution (95%) in the number of cases of polio since WHO launched The Global Polio Initiative has been very impressive. Only 94 cases had been reported world wide up to 30 March 2001. The success of this international cooperation has resulted in the last case in America being in 1991, in the Western Pacific Region in 1997. Europe had been polio-free for two years-until April 2001 when type 1 wild poliovirus, originating in northern India, was isolated from cases in Bulgaria.'.
However, the WHO initiative can be held back by civil and national wars, national disasters and political upheavals. Moreover, the occurrence of the Bulgarian cases in April 2001 and of 11 cases in the Dominican Republic and another in Haiti in 2000 re-emphasizes the need for polio-free areas to maintain high coverage with poliovaccine in the meantime.
Once cases of poliomyelitis cease to occur it should be possible to ultimately cease to immunize against the disease. As Mahler and Aylward indicate, large savings (£1 billion per year") could be made if this came about, releasing much needed health resources for other purposes. However, polio immunization and surveillance will need to continue for some years after eradication has been achieved.
At a recent round table meeting the issues and challenges associated with stopping polio immunization were discussed>, Several options were available; continue with childhood vaccination with OPV; change to an all-194 IPV programme; removal of one or two Sabin strains from OPV, or the use of monovalent OPV; or the discontinuation of OPV either world wide or selectively country-by-country. As Schaub'' points out the implications for the termination of vaccination are of considerable public health concern and a great deal more research will still need to be done before there is enough reassuring information to take the critical decision to stop vaccination with confidence.
Despite the impressive enthusiasm to finally rid the world of the scourge of polio there is at least one other potential hazard remaining and that is of the laboratory remaining a reservoir of potential infection.
The experience of the smallpox outbreak in Birmingham emanating from a virus laboratory has an important lesson to bring to the plans for the eradication of polio. As long as wild poliovirus continues to be present in laboratories (unless under very strictly controlled conditions) then there will always be the potential for virus to regain entry to the human population. Ironically, this hazard will be even greater when the eradication campaign becomes so successful that it will be possible to cease immunization. There will then be the situation in which an unimmunized population will be extremely vulnerable if poliovirus from the laboratory is inadvertently re-introduced.
In order that this risk is kept to the barest minimum strenuous efforts are being made by the WHO to ensure that a laboratory containment policy will be as effective as possible. Laboratories will be encouraged to destroy wild poliovirus infected material or send it to a national or international repository for safe keeping, where appropriate biosafety requirements for storage and handling can be ensured.
Although the goal of global eradication has not yet been reached the signs are so promising that it would be a tragedy if the reintroduction of polioviruses into the population occurred and jeopardized the success of such a worthwhile enterprise.
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